AAβ (n, %) | NO-AAβ (n, %) | p value | |
---|---|---|---|
Overall population | |||
Number | 872 | 1833 | |
MACE | 69 (7.92) | 108 (5.92) | 0.049 |
Cardiac-death | 28 (3.21) | 54 (2.96) | 0.720 |
All-cause death | 29 (3.3) | 62 (3.4) | 0.939 |
Target vascular reconstruction | 1 (0.11) | 0 (0) | 0.148 |
Recurrent myocardial infarction | 39 (4.48) | 45 (2.47) | 0.005 |
Malignant arrhythmia | 2 (0.23) | 2 (0.11) | 0.451 |
Cerebral infarction | 3 (0.35) | 7 (0.39) | 0.874 |
Cerebral hemorrhage | 3 (0.35) | 8 (0.44) | 0.718 |
Matched population | |||
Number | 226 | 452 | |
MACE | 13 (5.75) | 21 (4.65) | 0.53 |
Cardiac-death | 8 (3.54) | 12 (2.65) | 0.631 |
All-cause death | 8 (3.54) | 13 (2.88) | 0.638 |
Target vascular reconstruction | 0 (0) | 0 (0) | |
Recurrent myocardial infarction | 6 (2.65) | 7 (1.55) | 0.322 |
Malignant arrhythmia | 1 (0.44) | 2 (0.44) | 0.999 |
Cerebral infarction | 0 (0) | 3 (0.67) | 0.220 |
Cerebral hemorrhage | 0 (0) | 4 (0.89) | 0.157 |